3
SUMMARY
On a sequential basis, the company’s profit grew 25% from INR 38.3 Cr
The company’s operating revenue stood at INR 216.5 Cr during Q2 FY26, up 22% YoY and 12% QoQ
Its total expenses rose 10% YoY and 7% QoQ to INR 157.3 Cr
PharmEasy
-Owned diagnostics laboratories chain Thyrocare’s net profit surged 81% to INR 47.8 Cr in Q2 FY26 from INR 26.4 Cr in the year-ago quarter. On a sequential basis, the company’s profit grew 25% from INR 38.3 Cr.
The sharp rise in profit…
